Feature Rotating Article - BioPharm International

ADVERTISEMENT

Feature Rotating Article

Report from India

February 1, 2013

India's biopharmaceutical industry is valued at $2 billion a year with 20 companies producing biosimilars and 50 products available in the domestic market.

Assessing Development Needs for Biobetters and Biosimilars

February 1, 2013

Development requirements and regulatory guidance for biosimilars and biobetters.

Viral Vaccine Manufacturing

February 1, 2013

Tony Hitchcock of Cobra Biologics discusses challenges posed by production of viral vectors for vaccines.

Automated Concentration and Diafiltration of Multiple siRNA Samples

February 1, 2013

Project: transfer a manual concentration/diafiltration process for siRNA production.

Biologics: What Does the Future Hold?

January 1, 2013

Neil Lewis, chief technology officer at Malvern Instruments, talks about the challenges associated with biologics.

Bioconjugates: The Adaptable Challenge

January 1, 2013

Conjugation of a biologic to a carrier molecule can solve problems in solubility and stability, but introduces its own challenges.

A Look Ahead at BioPharma Manufacturing and Regulation

January 1, 2013

FDA talks about the changing scope of regulatory science.

Epigenetics Drives Pharma Innovation

January 1, 2013

Therapeutics targeting epigenetic mechanisms of disease will change the pharmaceutical marketplace.

The Future of Biopharma

January 1, 2013

What the industry's future holds and what needs to be done to get there.

ADVERTISEMENT

ADVERTISEMENT

Click here